Anavex Life Sciences (AVXL) Net Income Growth (3y) (2019 - 2025)
Anavex Life Sciences (AVXL) Net Income Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 9.16% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 38.43% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 13.80% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -3.84% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 79.26% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Anavex Life Sciences | 223.91 Mn | 92.16 Mn | - | -481.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -481.86% |
| Sep 30, 2025 | -1,306.08% |
| Jun 30, 2025 | -69.54% |
| Mar 31, 2025 | -69.85% |
| Dec 31, 2024 | -96.60% |
| Sep 30, 2024 | -0.43% |
| Jun 30, 2024 | -6.12% |
| Mar 31, 2024 | -8.83% |
| Dec 31, 2023 | -3.15% |
| Sep 30, 2023 | -19.37% |
| Jun 30, 2023 | -20.25% |
| Mar 31, 2023 | -21.90% |
| Dec 31, 2022 | -25.31% |
| Sep 30, 2022 | -36.60% |
| Jun 30, 2022 | -23.78% |
| Mar 31, 2022 | -12.93% |
| Dec 31, 2021 | -16.29% |
| Sep 30, 2021 | -27.51% |
| Jun 30, 2021 | -53.07% |
| Mar 31, 2021 | -19.86% |